Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group (Q44862011)
Jump to navigation
Jump to search
scientific article published in June 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group |
scientific article published in June 1999 |
Statements
1 reference
Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group (English)
1 reference
Marmarou A
1 reference
Nichols J
1 reference
Burgess J
1 reference
Newell D
1 reference
Troha J
1 reference
Burnham D
1 reference
Pitts L
1 reference
1 June 1999
1 reference
1 reference
Identifiers
1 reference